252 related articles for article (PubMed ID: 24817417)
1. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial.
Chevalier X; Ravaud P; Maheu E; Baron G; Rialland A; Vergnaud P; Roux C; Maugars Y; Mulleman D; Lukas C; Wendling D; Lafforgue P; Loeuille D; Foltz V; Richette P;
Ann Rheum Dis; 2015 Sep; 74(9):1697-705. PubMed ID: 24817417
[TBL] [Abstract][Full Text] [Related]
2. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial.
Aitken D; Laslett LL; Pan F; Haugen IK; Otahal P; Bellamy N; Bird P; Jones G
Osteoarthritis Cartilage; 2018 Jul; 26(7):880-887. PubMed ID: 29499287
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial.
Richette P; Latourte A; Sellam J; Wendling D; Piperno M; Goupille P; Pers YM; Eymard F; Ottaviani S; Ornetti P; Flipo RM; Fautrel B; Peyr O; Bertola JP; Vicaut E; Chevalier X
Ann Rheum Dis; 2021 Mar; 80(3):349-355. PubMed ID: 33055078
[TBL] [Abstract][Full Text] [Related]
4. Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial.
Jacquet A; Girodet PO; Pariente A; Forest K; Mallet L; Moore N
Arthritis Res Ther; 2009; 11(6):R192. PubMed ID: 20015358
[TBL] [Abstract][Full Text] [Related]
5. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis.
Wenham CY; Hensor EM; Grainger AJ; Hodgson R; Balamoody S; Doré CJ; Emery P; Conaghan PG
Rheumatology (Oxford); 2012 Dec; 51(12):2286-94. PubMed ID: 22956551
[TBL] [Abstract][Full Text] [Related]
8. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial.
Kloppenburg M; Ramonda R; Bobacz K; Kwok WY; Elewaut D; Huizinga TWJ; Kroon FPB; Punzi L; Smolen JS; Vander Cruyssen B; Wolterbeek R; Verbruggen G; Wittoek R
Ann Rheum Dis; 2018 Dec; 77(12):1757-1764. PubMed ID: 30282670
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.
Detert J; Klaus P; Listing J; Höhne-Zimmer V; Braun T; Wassenberg S; Rau R; Buttgereit F; Burmester GR
Trials; 2014 Oct; 15():412. PubMed ID: 25348033
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
Sieper J; van der Heijde D; Dougados M; Mease PJ; Maksymowych WP; Brown MA; Arora V; Pangan AL
Ann Rheum Dis; 2013 Jun; 72(6):815-22. PubMed ID: 22772328
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.
Ritchlin C; Rahman P; Kavanaugh A; McInnes IB; Puig L; Li S; Wang Y; Shen YK; Doyle MK; Mendelsohn AM; Gottlieb AB;
Ann Rheum Dis; 2014 Jun; 73(6):990-9. PubMed ID: 24482301
[TBL] [Abstract][Full Text] [Related]
13. Tramadol for osteoarthritis.
Toupin April K; Bisaillon J; Welch V; Maxwell LJ; Jüni P; Rutjes AW; Husni ME; Vincent J; El Hindi T; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2019 May; 5(5):CD005522. PubMed ID: 31132298
[TBL] [Abstract][Full Text] [Related]
14. Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial.
Brown MT; Murphy FT; Radin DM; Davignon I; Smith MD; West CR
J Pain; 2012 Aug; 13(8):790-8. PubMed ID: 22784777
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center.
Gabay C; Medinger-Sadowski C; Gascon D; Kolo F; Finckh A
Arthritis Rheum; 2011 Nov; 63(11):3383-91. PubMed ID: 21898340
[TBL] [Abstract][Full Text] [Related]
16. The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial.
Scott DL; Berry H; Capell H; Coppock J; Daymond T; Doyle DV; Fernandes L; Hazleman B; Hunter J; Huskisson EC; Jawad A; Jubb R; Kennedy T; McGill P; Nichol F; Palit J; Webley M; Woolf A; Wotjulewski J
Rheumatology (Oxford); 2000 Oct; 39(10):1095-101. PubMed ID: 11035129
[TBL] [Abstract][Full Text] [Related]
17. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
[TBL] [Abstract][Full Text] [Related]
18. Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial.
Kroon FPB; Kortekaas MC; Boonen A; Böhringer S; Reijnierse M; Rosendaal FR; Riyazi N; Starmans M; Turkstra F; van Zeben J; Allaart CF; Kloppenburg M
Lancet; 2019 Nov; 394(10213):1993-2001. PubMed ID: 31727410
[TBL] [Abstract][Full Text] [Related]
19. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
[TBL] [Abstract][Full Text] [Related]
20. Evolution of pain at 3 months by oral resveratrol in knee osteoarthritis (ARTHROL): protocol for a multicentre randomised double-blind placebo-controlled trial.
Nguyen C; Boutron I; Baron G; Coudeyre E; Berenbaum F; Poiraudeau S; Rannou F
BMJ Open; 2017 Sep; 7(9):e017652. PubMed ID: 28965100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
